vasostatin-2在轻中度原发性高血压患者中的表达水平研究

陈长源, 白明, 赵存瑞, 等. vasostatin-2在轻中度原发性高血压患者中的表达水平研究[J]. 临床心血管病杂志, 2016, 32(10): 1021-1023. doi: 10.13201/j.issn.1001-1439.2016.10.013
引用本文: 陈长源, 白明, 赵存瑞, 等. vasostatin-2在轻中度原发性高血压患者中的表达水平研究[J]. 临床心血管病杂志, 2016, 32(10): 1021-1023. doi: 10.13201/j.issn.1001-1439.2016.10.013
CHEN Zhangyuan, BAI Ming, ZHAO Cunrui, et al. Changes of circulating plasma vasostatin-2 levels and its significance in patients with mild-to-moderate hypertension[J]. J Clin Cardiol, 2016, 32(10): 1021-1023. doi: 10.13201/j.issn.1001-1439.2016.10.013
Citation: CHEN Zhangyuan, BAI Ming, ZHAO Cunrui, et al. Changes of circulating plasma vasostatin-2 levels and its significance in patients with mild-to-moderate hypertension[J]. J Clin Cardiol, 2016, 32(10): 1021-1023. doi: 10.13201/j.issn.1001-1439.2016.10.013

vasostatin-2在轻中度原发性高血压患者中的表达水平研究

  • 基金项目:

    兰州大学中央高校基本科研业务费专项资金(No:lzujbky-2013-218)

详细信息
    通讯作者: 张钲,E-mail:zhangccu@yahoo.com.cn
  • 中图分类号: R544.1

Changes of circulating plasma vasostatin-2 levels and its significance in patients with mild-to-moderate hypertension

More Information
  • 目的:观察未经药物治疗的轻中度原发性高血压患者外周血vasostatin-2(VS-2)水平的变化并阐明其临床意义。方法:采用ELISA方法检测89例原发性高血压患者和76例正常血压对照者空腹外周血VS-2水平并比较其BMI、静息心率等指标。结果:与对照组比较,高血压组患者血浆VS-2水平升高[(0.24±0.04)pg/ml︰(0.32±0.06)pg/ml,P<0.05]。Pearson相关分析显示,平均动脉压及静息心率与VS-2水平呈正相关(r分别为0.301、0.427,均P<0.01),而年龄、BMI、血脂及空腹血糖与VS-2水平无关。多元线性回归分析显示,校正年龄、BMI、血脂、血糖等因素后,平均动脉压及静息心率是血浆VS-2水平的独立影响因子(均P<0.05)。结论:未经治疗的原发性高血压患者外周血VS-2水平升高,提示其拮抗过度激活的交感神经系统,可能在高血压病理状态下发挥心血管保护作用。
  • 加载中
  • [1]

    D'AMICO M A,GHINASSI B,IZZICUPO P,et al.Biological function and clinical relevance of chromogranin A and derived peptides[J].Endocr Connect,2014,29:R45-54.

    [2]

    AARDAL S,HELLE K B,ELSAYED S,et al.Vasostatins,comprising the N-terminal domain of chromogranin A,suppress tension in isolated human blood vessel segments[J].J Neuroendocrinol,1993,5:405-412.

    [3]

    HELLE K B,AUNIS D.A physiological role for the granins as prohormones for homeostatically important regulatory peptides?A working hypothesis for futu-re research[J].Adv Exp Med Biol,2000,482:389-397.

    [4]

    中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.

    [5]

    SAHU B S,SONAWANE P J,MAHAPATRA N R.Chromogranin A:a novel suscepti-bility gene for essential hypertension[J].Cell Mol Life Sci,2010,67:861-874.

    [6]

    TOTA B,ANGELONE T,CERRA M C.The surging role of Chromogranin A in car-diovascular homeostasis[J].Front Chem,2014,2:64.

    [7]

    HELLE K B,CORTI A.Chromogranin A:aparadoxical player in angiogenesis a-nd vascular biology[J].Cell Mol Life Sci,2015,72:339-348.

    [8]

    IMBROGNO S,ANGELONE T,CORTI A,et al.Influence of vasostatins,the chromog-ranin A-derived peptides,on the working heart of the eel(Anguilla anguilla):ne-gative inotropy and mechanism of action[J].Gen Comp Endocrinol,2004,139:20-28.

    [9]

    CORTI A,MANNARINO C,MAZZA R,et al.Vasostatins exert negative inotropism in the working heart of the frog[J].Ann N Y Acad Sci,2002,971:362-365.

    [10]

    LU L,WANG Y N,LI M C,et al.Reduced serum levels of vasostatin-2,an anti-inflammatory peptide derived from chromogranin A,are associated with the presence and severity of coronary artery disease[J].Eur Heart J,2012,33:2297-2306.

    [11]

    PAN W Q,HE Y H,SU Q,et al.Association of decreased serum vasostatin-2l-evel with ischemic chronic heart failure and with MACE in 3-yearfollow-up:Vaso-statin-2prevents heart failure in myocardial infarction rats[J].Int J Cardiol,221:1-11.

    [12]

    TOTA B,QUINTIERI A M,DI FELICE V,et al.New biological aspects of chromogr-anin-A derived peptides:focus on vasostatins[J].Comp Biochem Physiol A Mol Integr Physiol,2007,147:11-18.

    [13]

    陈长源,白明,康宏,等.经静脉注射血管内皮抑制因子-2对自发性高血压大鼠血流动力学影响的研究[J].中国循环杂志,2016,31(2):180-184.

    [14]

    陈长源,白明,张钲.嗜铬粒蛋白A衍生多肽在心血管领域研究进展[J].临床心血管病杂志,2016,32(1):82-85.

  • 加载中
计量
  • 文章访问数:  77
  • PDF下载数:  27
  • 施引文献:  0
出版历程
收稿日期:  2016-02-25
修回日期:  2016-08-01

目录